David Tepper’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

David Tepper’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-330,000	Closed	-$25.5M	–	59
2017 Q2	$25.5M	Buy	+330,000	New	+$23.4M	0.38%	44

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

David Tepper's XBI Position: Q3 2017 in Review

David Tepper sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2017, closing a stake of 330,000 shares — an estimated $25.5M sold.

David Tepper first reported a position in XBI in Q2 2017 and held it in 1 quarter. The position peaked at $25.5M in Q2 2017. 349 funds tracked by Wall St. Rank hold XBI as of Q3 2017.

David Tepper reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2017 after selling out during the quarter.
David Tepper sold 330,000 State Street SPDR S&P Biotech ETF shares in Q3 2017, an estimated $25.5M.
David Tepper first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and held it in 1 quarter.
David Tepper's State Street SPDR S&P Biotech ETF position peaked at $25.5M in Q2 2017.
349 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2017.

Based on Appaloosa LP's 13F filing for Q3 2017, filed 14 Nov 2017.